Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Apatinib Combined With
CHOP Regimen(cyclophosphamide, vincristine, epirubicin, prednisone in the treatment of newly
diagnosed peripheral T-cell lymphoma.